Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma

Aqueous Shunts and Stents for Glaucoma

©2017 Blue Cross and Blue Shield of Louisiana An independent licensee of the Blue Cross and Blue Shield Association No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, or otherwise, without permission from Blue Cross and Blue Shield of Louisiana. Page 1 of 17 Applies to all products admin...

Aqueous Shunts and Stents for Glaucoma

©2014 Blue Cross and Blue Shield of Louisiana An independent licensee of the Blue Cross and Blue Shield Association No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, or otherwise, without permission from Blue Cross and Blue Shield of Louisiana. Page 1 of 11 Applies to all products admin...

Aqueous Shunts and Stents for Glaucoma

Background/Overview Glaucoma surgery is intended to reduce IOP when the target IOP cannot be reached with medications. Due to complications with established surgical approaches such as trabeculectomy, a variety of shunts are being evaluated as alternative surgical treatments for patients with inadequately controlled glaucoma. Microstents are also being evaluated in patients with mild to moderat...

mitomycin-c trabeculectomy versus ahmed glaucoma implant for treatment of pediatric aphakic glaucoma

purpose: to compare the outcomes and complications of mitomycin-c (mmc) trabeculectomy and ahmed glaucoma implant (agi) for treatment of aphakic glaucoma following congenital cataract surgery in children £ 16 years of age. methods: in a randomized clinical trial, eligible children were randomly assigned to mmc trabeculectomy or agi. aphakia was due to previous anterior lensectomy and vitrectomy...

Nephrology, Transplantation and Shunts